Skip to main content
. 2019 Feb 28;19(4):443–454. doi: 10.1111/papr.12760

Table 1.

Overview of Abuse‐Deterrent Approaches15, 53

Abuse‐Deterrent Approach Properties
Physical and chemical barriers Resists chewing, crushing, cutting, grating, grinding, pulverizing; dissolving produces a viscous substance that cannot be drawn into a syringe
Agonist‐antagonist combination Opioid with a corresponding antagonist (to reduce or defeat euphoria associated with abuse; antagonist released only through tampering)
Aversive agent Opioid is combined with an aversive agent released during tampering (eg, nasal irritant)
Delivery system Method of drug delivery offers resistance to abuse (eg, sustained‐release depot injectable, subcutaneous implant)
Prodrug Opioid is released after the parent drug is ingested and metabolized (usually requires stomach enzyme); opioid is not activated through alternative route of administration

Adapted with permission from Institute for Clinical and Economic Review53; with additional data from U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research.15